Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Drug Safety is Scopus-indexed (Q2, CiteScore 4.6), WoS SCIE, DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2042-0986Verify ISSN ↗2042-0994Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 115 / 278 | 58th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q2, CiteScore 4.6.
Therapeutic Advances in Drug Safety is Q2 in Pharmacology (medical) (rank 115 of 278), by CiteScore 2025.
Therapeutic Advances in Drug Safety is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q2 at the 58th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.833, quartile Q2, with an H-index of 55.
The publisher lists an article processing charge of about US$2,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Therapeutic Advances in Drug Safety is published by SAGE Publications Ltd. Its print ISSN is 2042-0986 and its online ISSN is 2042-0994.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Therapeutic Advances in Drug Safety has an h-index of 65 and a 2-year mean of 3.89 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q2. On 2-year citations it ranks #54 of 271 Scopus journals in Pharmacology (medical).
Therapeutic Advances in Drug Safety published 68 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2025–2026), authors are most often from China (29.1%), United States (13.7%) and Canada (5.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.